On November 4, the Board of Directors of China Biologic Products, Inc. appointed Mr. David Li as a director of the company, effective from the same date thereof. Mr. David Li has served as a Managing Director of Warburg Pincus Asia LLC since 2002.
China Biologic Products Holdings, Inc.
Equities
CBPO
KYG215151047
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |